Unum Therapeutics to raise about $104.4m

Cambridge, Massachusetts-based Unum Therapeutics Inc, a biopharmaceutical company focused on developing therapies for solid tumors, is expected to raise about $104.4 million in a private placement.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this